Dr Keravec joined DNDi in January 2016, with more than two decades of experience managing global public-health-care programs in Latin America, Africa, Asia and Europe. In the last three years he has led the Global Drug Facility of Stop TB Partnerships in Geneva, where he set up a new business model which resulted in enhanced operational efficiency in more than 130 countries and significant reductions in the cost of drugs used to treat multi drug-resistant tuberculosis. He headed the Management Sciences for Health (MSH) office in Brazil from 2004 to 2012.
His professional trajectory includes the World Health Organization (WHO) and United Nations as the United Nations Office for Services and Projects (UNOPS), Pan American Health Organization (PAHO), Management Science for Health(MSH), USaid; and the Ministry for Foreign Affairs of France – in addition to the Brazilian National Health Surveillance Agency (Anvisa), as vice-director of the Health Care Quality Control Institute / Oswaldo Cruz Foundation and the Ministry of Health in Brazil.
His experience in public health care includes epidemiology, development and management of medication, quality assurance and international quality standards (ISO) in medication laboratory management, collaboration with the WHO’s prequalification program for essential medication, the political and regulatory framework in the medication sector, support for the management and incorporation of new treatments against tuberculosis in several countries. In addition to these fields, he has worked in improving access to essential medication treatments and enhancing and developing integrated information and technology systems solutions for healthcare (e-health) and e-TB Manager.
Dr Keravec graduated from the National Veterinary School of Nantes, France, with a PhD in Epidemiology from the medicine faculty of Nantes / Instituto Pasteur. He also has a Master’s degree in business management (MBA) from Institut Supérieur des Affaires, Groupe HEC, Paris.